Modified stem cells tested as potential lifeline for severe sickle cell patients
NCT ID NCT07436767
Summary
This early study is testing a single injection of modified stem cells in three people with severe sickle cell disease. The goal is to see if these specially altered cells can safely take hold in the body and start producing healthier red blood cells. Researchers hope this approach will reduce the painful crises and complications of the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.